Nanomedicine Research Journal

Nanomedicine Research Journal

Synergistic Anticancer Effects of Aluminum Oxide Nanoparticle (Al2O3NPs) Combined with Doxorubicin in Inhibiting SK-OV-3 Ovarian Cancer Cell Proliferation

Document Type : Original Research Article

Authors
Ehsan Ghassemi Barghi 1
Jafar Gholami Gharab 2
Nasrin Ghassemi Barghi 2, 3
1 Department of Health Information Management and Medical Informatics, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
2 Kimiagaran Salamat Gostar Pars Teb Company, Tehran, Iran
3 Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran
10.22034/nmrj.2024.04.007
Abstract
Ovarian cancer, particularly aggressive subtypes like SK-OV-3, remains a significant challenge due to limited treatment options, necessitating the development of more effective therapeutic strategies. Aluminum oxide nanoparticle (Al2O3NPs) have demonstrated potential in cancer therapy because of their unique properties, including enhanced drug delivery and cytotoxic effects. This study investigates the synergistic anticancer effects of aluminum nanoparticles combined with doxorubicin on SK-OV-3 ovarian cancer cells. The effectiveness of the combination treatment was assessed by evaluating cell viability using the MTT assay. Oxidative stress was quantified by measuring reactive oxygen species (ROS) levels with the DCFH reagent, while lipid peroxidation (LPO) was analyzed by detecting malondialdehyde (MDA) levels. The antioxidant capacity was measured by assessing glutathione (GSH) levels. The results indicated that the combination of Al2O3NPs and doxorubicin significantly reduced SK-OV-3 cell viability, suggesting potent anticancer effects. Additionally, the treatment induced oxidative stress, as evidenced by increased ROS production, elevated MDA levels, and decreased GSH levels. These findings demonstrate that aluminum nanoparticles, in combination with doxorubicin, exert a synergistic anticancer effect by promoting oxidative stress and inhibiting the proliferation of SK-OV-3 cells. These findings underscore the potential of Al2O3NPs as an effective therapeutic modality in ovarian cancer treatment, particularly for aggressive subtypes like SK-OV-3.
Keywords
Aluminum oxide nanoparticle (Al2O3NPs)
Doxorubicin
Ovarian cancer
Oxidative stress
Cytotoxicity

Subjects

1.    Arora T, Mullangi S, Lekkala MR. Ovarian cancer. 2021. 
2.    Zhang R, Siu MK, Ngan HY, Chan KK. Molecular biomarkers for the early detection of ovarian cancer. Int J Mol Sci. 2022;23(19):12041. https://doi.org/10.3390/ijms231912041
3.    Li H, et al. Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications. Oncol Rep. 2021;46(4):1-27. https://doi.org/10.3892/or.2021.8174
4.    Chen J, et al. Recent advances in understanding the immune microenvironment in ovarian cancer. Front Immunol. 2024;15:1412328. https://doi.org/10.3389/fimmu.2024.1412328
5.    Naimi A, et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun Signal. 2022;20(1):44. https://doi.org/10.1186/s12964-022-00854-y
6.    Emeihe EV, et al. Revolutionizing drug delivery systems: Nanotechnology-based approaches for targeted therapy. Int J Life Sci Res Arch. 2024;7(1):40-58. https://doi.org/10.53771/ijlsra.2024.7.1.0060
7.    Zhang Q. Alumina Nanoparticles Induced Neurotoxic and Neurodevelopmental Toxic Effects. In: Neurotoxicity of Aluminum. Springer; 2023:255-313. https://doi.org/10.1007/978-981-99-1592-7_14
8.    Motafeghi F, Mortazavi P, Shokrzadeh M. Anticancer activity of zinc oxide nanoparticles on prostate and colon cancer cell line. Toxicol Res. 2024;13(1):tfad127. https://doi.org/10.1093/toxres/tfad127
9.    Motafeghi F, et al. Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line. Iran J Basic Med Sci. 2023;26(1):57.
10.    Patel TA, et al. Role of nanoparticle-conjugates and nanotheranostics in abrogating oxidative stress and ameliorating neuroinflammation. Antioxidants. 2023;12(10):1877. https://doi.org/10.3390/antiox12101877
11.    Kciuk M, et al. Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells. 2023;12(4):659. https://doi.org/10.3390/cells12040659
12.    Rawat PS, et al. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother. 2021;139:111708. https://doi.org/10.1016/j.biopha.2021.111708
13.    Maity S, et al. Doxorubicin-intercalated Li-Al-based LDHs as potential drug delivery nanovehicle with pH-responsive therapeutic cargo for tumor treatment. ACS Biomater Sci Eng. 2024;10(10):6377-96. https://doi.org/10.1021/acsbiomaterials.4c01289
14.    Piktel E, et al. ROS-mediated apoptosis and autophagy in ovarian cancer cells treated with peanut-shaped gold nanoparticles. Int J Nanomedicine. 2021;16:1993-2011. https://doi.org/10.2147/IJN.S277014
15.    Zahra KF, et al. The involvement of the oxidative stress status in cancer pathology: a double view on the role of the antioxidants. Oxid Med Cell Longev. 2021;2021:9965916. https://doi.org/10.1155/2021/9965916
16.    Rampin A, et al. Recent advances in KEAP1/NRF2-targeting strategies by phytochemical antioxidants, nanoparticles, and biocompatible scaffolds for the treatment of diabetic cardiovascular complications. Antioxid Redox Signal. 2022;36(10):707-28. https://doi.org/10.1089/ars.2021.0134
17.    Ghassemi-Barghi N, et al. Mechanistic approach for protective effect of ARA290, a specific ligand for the erythropoietin/CD131 heteroreceptor, against cisplatin-induced nephrotoxicity, the involvement of apoptosis and inflammation pathways. Inflammation. 2023;46(1):342-58. https://doi.org/10.1007/s10753-022-01737-7
18.    Motafeghi F, et al. Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action. Toxicol Res. 2023;12(4):702-8. https://doi.org/10.1093/toxres/tfad060
19.    Shokrzadeh M, et al. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:1803-13. https://doi.org/10.1007/s00210-021-02119-w
20.    Shokrzadeh M, et al. Cytotoxicity and mineralization activity of calcium silicate-based root canal sealers compared to conventional resin-based sealer in human gingival fibroblast cells. Int J Dent. 2023;2023:4376579. https://doi.org/10.1155/2023/4376579
21.    Ashari S, et al. Dimethyl fumarate attenuates di-(2-ethylhexyl) phthalate-induced nephrotoxicity through the Nrf2/HO-1 and NF-κB signaling pathways. Inflammation. 2023;46(1):453-67. https://doi.org/10.1007/s10753-022-01746-6
22.    Motafeghi F, et al. Kombucha mushroom extract: anticancer, antioxidant, and antimicrobial properties. Appl In Vitro Toxicol. 2023;9(3):90-103. https://doi.org/10.1089/aivt.2023.0005
23.    Ghassemi-Barghi N, et al. Role of recombinant human erythropoietin loading chitosan-tripolyphosphate nanoparticles in busulfan-induced genotoxicity: Analysis of DNA fragmentation via comet assay in cultured HepG2 cells. Toxicol In Vitro. 2016;36:46-52. https://doi.org/10.1016/j.tiv.2016.07.001
24.    Motafeghi F, et al. Synergistic Effect of Selenium/Zinc with Sulfasalazine on the Human Colorectal Cancer Cell Line (HT-29). Appl In Vitro Toxicol. 2023;9(1):3-12. https://doi.org/10.1089/aivt.2022.0007
25.    Shokrzadeh M, Ghassemi-Barghi N. Melatonin loading chitosan-tripolyphosphate nanoparticles: Application in attenuating etoposide-induced genotoxicity in HepG2 cells. Pharmacology. 2018;102(1-2):74-80. https://doi.org/10.1159/000489667
26.    Motafeghi F, et al. Anticancer effect of paroxetine and amitriptyline on HT29 and A549 cell lines. Toxicol In Vitro. 2023;87:105532. https://doi.org/10.1016/j.tiv.2022.105532
27.    Thorn CF, et al. Doxorubicin pathways: pharmacodynamics  and adverse effects. Pharmacogenet Genomics. 2011;21(7):440-6. https://doi.org/10.1097/FPC.0b013e3283 3ffb56
28.    Prathumsap N, et al. Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies. Eur J Pharmacol. 2020;866:172818. https://doi.org/10.1016/j.ejphar.2019.172818
29.    Wu BB, et al. Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity. Int J Mol Sci. 2022;23(3):1912. https://doi.org/10.3390/ijms23031912
30.    Renu K, et al. Toxic effects and molecular mechanism of doxorubicin on different organs-an update. Toxin Rev. 2022;41(2):650-74. https://doi.org/10.1080/15569543.2021.1912099
31.    Schirone L, et al. Mitochondria and doxorubicin-induced cardiomyopathy: a complex interplay. Cells. 2022;11(13):2000. https://doi.org/10.3390/cells11132000
32.    Vitale R, Marzocco S, Popolo A. Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account. Int J Mol Sci. 2024;25(13):7477. https://doi.org/10.3390/ijms25137477
33.    Majdalawieh A, et al. Recent advances in gold and silver nanoparticles: synthesis and applications. J Nanosci Nanotechnol. 2014;14(7):4757-80. https://doi.org/10.1166/jnn.2014.9526
34.    Malik P, Mukherjee TK. Recent advances in gold and silver nanoparticle based therapies for lung and breast cancers. Int J Pharm. 2018;553(1-2):483-509. https://doi.org/10.1016/j.ijpharm.2018.10.048
35.    Moawad M, et al. Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells. Egypt J Chem. 2024;67(1):505-12.
36.    El-Hussainy E-HM, et al. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can J Physiol Pharmacol. 2016;94(8):868-78. https://doi.org/10.1139/cjpp-2015-0446
37.    Sabourian P, et al. Effect of physico-chemical properties of nanoparticles on their intracellular uptake. Int J Mol Sci. 2020;21(21):8019. https://doi.org/10.3390/ijms21218019
38.    Ghelani D, Faisal S. Synthesis and characterization of Aluminium Oxide nanoparticles. Authorea Preprints. 2022 https://doi.org/10.22541/au.166490972.20428974/v
Nanomedicine Research Journal
Volume 9, Issue 4
Autumn 2024
Pages 402-410